DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

EVONILE vs GKB: Stock Comparison

EVONILE PHARMA vs GKB OPHTHALMICSUpdated 6 Nov 26, 4:08 PM ISTNSE & company filings

EVONILE PHARMA is the larger company by market capitalisation. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

EVONILE leads 0; GKB leads 0 of 4

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

EVONILEGKB

Valuation lens

What price are you paying?

Market CapContext only
₹4,233 Cr
₹30 Cr
P/E RatioSame reading
0x
—
P/B RatioSame reading
0x
—
EPSSame reading
—
₹2
Book ValueContext only
—
₹108.89
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
EVONILE is the larger company
₹4,233 Cr vs ₹30 Cr

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricEVONILEGKB
Live Price₹1,758.4₹59.56
Day Change2.44%-1.75%
Volume52,6541,925
52-Week High₹1,738₹76.02
52-Week Low₹1,600.1₹55.01
Distance from 52W High1.17%-21.65%

Valuation

MetricEVONILEGKB
Market Cap₹4,233 Cr₹30 Cr
P/E Ratio0x—
P/B Ratio0x—
EPS—₹2
Book Value—₹108.89
Dividend Yield0%0%

Growth

MetricEVONILEGKB
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth—0%
Qtr Profit Growth—0%

Profitability & Leverage

MetricEVONILEGKB
Net Margin0%0%

Shareholding

As of Jun 2026 • change vs previous quarter
MetricEVONILEGKB
Promoter Holding—51.15%▲ 0.02 pp
FII Holding—1.79%
DII Holding—0%
Public Holding—47.07%▼ 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: EVONILE PHARMA and GKB OPHTHALMICS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.